Topic List : COVID-19
Stanford can begin pooled testing for COVID-19
A Stanford Medicine test for the coronavirus has been validated for pooled testing. This method greatly increases testing capacity and conserves testing resources, which continue to be in short supply.
How pathogens put the brakes on immune response
Researchers at the Stanford School of Medicine have discovered that cells infected by viruses or bacteria send out a “don’t eat me” signal to avoid attack by the body’s immune system.
Anthony Fauci talks COVID-19 with dean
The nation’s top infectious disease expert spoke with School of Medicine Dean Lloyd Minor about the challenges posed by COVID-19, the hope for emerging vaccines and treatments, and what’s still unknown about the virus.
Study to look at oral drug for COVID-19
Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19.
How ICU team took on COVID-19
With no clear guidelines on how to treat its first coronavirus patients, the ICU used teamwork to find its way through.
Scientists contribute to WHO mask guidelines
Scientists say we should wear masks to control the spread of COVID-19. Stanford experts share the evidence that informed the World Health Organization’s recommendations.
Stanford Health Care nears 75,000 COVID-19 tests
As one of the earliest providers of COVID-19 testing to the greater Bay Area, Stanford Health Care has conducted nearly 75,000 tests for the local community and continues to be a leading resource.
Self-swabbing tests for COVID-19 accurate
People can be taught to do their own nasal swabs for accurate COVID-19 testing, limiting the exposure of health care workers and the use of protective equipment, according to Stanford researchers.
Procedures, routine visits again scheduled
With Stanford physicians once again performing nonemergency procedures, patient Anwar Soliman underwent surgery to relieve his back pain and acid reflux.
COVID-19 drug for outpatients tested
Scientists at Stanford Medicine are investigating whether a molecule called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce their transmission of the disease-causing virus.